MasterControl CEO Jon Beckstrand Austen Diamond Photograhy Most software startups seek venture funding in the early stages. MasterControl, which provides quality and manufacturing software for life sc...
Tag: life sciences
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...
GE HealthCare Is Going Independent. This Is Where the Stock Should Trade.
Text size GE HealthCare should generate about $3.3 billion in Ebitda for all of 2022. Kamil Krzaczynski/Getty Images To start 2023, investors will have a choice to invest in a brand new $18 billion co...
Horizon Therapeutics, Coupa Software, Rivian, and More Stock Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Novozymes and Chr. Hansen agree deal to merge
Danish biotechnology companies Novozymes AS NZYM.B, -13.67% and Chr. Hansen Holding AS CHR, +23.64% said Monday they have agreed to merge, creating a biological solutions provider with combined annual...
Paccar, Deere, and 10 More Companies That Raised Their Stock Dividends This Week
Text size Paccar said it will boost its regular dividend to 25 cents a share. Dreamstime Carrier Global, Deere , Zoetis , and Paccar were among the many large U.S. companies that declared dividend inc...
CVS Wants to Be a Healthcare Provider. So Why Doesn’t It Have Any Doctors?
Late last year, CVS Health CEO Karen Lynch unveiled a new strategy: Rather than remain simply a pit stop for toilet paper and flu shots, CVS stores would become a place that Americans—particularly old...
GE Healthcare Plans to Reduce Debt and Costs, Pursue Tuck-In Acquisitions
General Electric Co.’s healthcare division plans to cut debt, bring down costs and pursue tuck-in acquisitions after its spinoff in early January, finance chief Helmut Zodl said Thursday at an investo...
BNP Paribas studied 100 years of market crashes — here’s what it says is coming next
Oops. Stocks fell through a key support on Tuesday and it looks like some recent momentum has now petered out. The new line in the sand for the S&P 500 SPX, -1.44% seems to be 3,900. Whether Santa...
Elizabeth Holmes Sentencing: A History of the WSJ Theranos Investigation
By Michael Siconolfi Nov. 18, 2022 5:30 am ET Listen to article (2 minutes) Elizabeth Holmes’s journey from Silicon Valley superstar to felon is slated to culminate Friday during a hearing in which a ...
Sunrun and Other Solar Stocks With Strong U.S. Presence Are a Buy, Analyst Says
An analyst from Deutsche Bank is bullish on Enphase Energy Sunrun and First Solar due to their strong domestic presence amid new U.S. legislation. Deutsche Bank analyst Corinne Blanchard initiated cov...
FTX’s stunning collapse nothing like Theranos, says venture investor and crypto bull Tim Draper
Tim Draper, founder and managing partner of Draper Associates and Draper University, balked at comparing the stunning implosion of crypto trading platform FTX to the notorious biotech startup Theranos...
Big Pharma Stocks Are Breaking Out. Here Are Some Winners.
Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs. These stocks had been outpe...
Pfizer Stock’s Post-Covid Future Looks Healthy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say
The AARP name has become a marketing juggernaut among baby boomers, with the group’s nearly 38 million members receiving offers for AARP-branded health, life and auto insurance, and discounts on cellp...
AbbVie Stock Slips as Sales Miss Expectations And Bigger Challenges Await.
Stock in AbbVie slipped after the drug company reported a higher profit than expected, while sales fell short. The revenue shortfall may have reminded investors of a challenge AbbVie (ticker: ABBV) fa...
Medtronic Is Doing a Spinoff. What It Means for Our Stock Pick.
Medical device maker Medtronic is spinning off two business units to try to drive higher growth. The market isn’t impressed. In theory, it should be. Spinoffs are supposed to streamline operations of...
These 27 stocks can give you a more diversified portfolio than the S&P 500 — and that’s a key advantage right now
You probably already know that because of market-capitalization weighting, a broad index such as the S&P 500 SPX, -0.80% can be concentrated in a handful of stocks. Index funds are popular for goo...
Tesla, Goldman Sachs, Netflix, AT&T, and Other Stocks for Investors to Watch This Week
We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...
10 Dividend Aristocrat stocks expected by analysts to rise up to 54% in 2023
Stocks of companies that raise dividends consistently have outperformed during this year’s bear market. Below is a screen showing which stocks are analysts’ favorites for next year among an expanded l...